Indonésie < Iran < Irlande (pays)

Facettes : Author.f AffPays.f

List of bibliographic references

Number of relevant bibliographic references: 23.
[0-20] [0 - 20][0 - 23][20-22][20-40]

Ident.	Authors (with country if any)	Title
000041 (2020)	Hadir Shakshouk [États-Unis, Égypte] ; Maryam Daneshpazhooh [Iran] ; Dedee F. Murrell [Australie] ; Julia S. Lehman [États-Unis]	Treatment considerations for patients with pemphigus during the COVID-19 pandemic
000059 (2020)	Banafsheh Mosharmovahed [Iran] ; Yousef Fatahi [Iran] ; Bahareh Mohebbi [Iran] ; Sohrab Ali Ghorbanian [Iran] ; Sara Assadiasl [Iran]	Tocilizumab in transplantation.
000106 (2020)	Akram Aminjafari [Iran] ; Sorayya Ghasemi [Iran]	The Possible of Immunotherapy for COVID-19: a Systematic Review
000216 (2020)	Elaheh Kordzadeh-Kermani [Iran] ; Hossein Khalili [Iran] ; Iman Karimzadeh [Iran] ; Mohammadreza Salehi [Iran]	Prevention Strategies to Minimize the Infection Risk Associated with Biologic and Targeted Immunomodulators
000225 (2020)	Ali Rismanbaf [Iran]	Potential Treatments for COVID-19; a Narrative Literature Review
000334 (2020)	Amin Gasmi [France] ; Sadaf Noor [Pakistan] ; Torsak Tippairote [Thaïlande] ; Maryam Dadar [Iran] ; Alain Menzel [France] ; Geir Bj Rklund [Norvège]	Individual risk management strategy and potential therapeutic options for the COVID-19 pandemic
000395 (2020)	Mohsen Jari [Iran] ; Reza Shiari [Iran] ; Omid Salehpour [Iran] ; Khosro Rahmani [Iran]	Epidemiological and advanced therapeutic approaches to treatment of uveitis in pediatric rheumatic diseases: a systematic review and meta-analysis
000475 (2020)	Farzaneh Dastan [Iran] ; Ali Saffaei [Iran] ; Seyed Mehdi Mortazavi [Iran] ; Hamidreza Jamaati [Iran] ; Nadia Adnani [Iran] ; Sasan Samiee Roudi [Iran] ; Arda Kiani [Iran] ; Atefeh Abedini [Iran] ; Seyed Mohammadreza Hashemian [Iran]	Continues Renal Replacement Therapy (CRRT) With Disposable Hemoperfusion Cartridge: A Promising Option for Severe COVID-19
000565 (2020)	Ali Aminian [États-Unis] ; Mohammad Kermansaravi [Iran] ; Shahriar Azizi [Iran] ; Peyman Alibeigi [Iran] ; Sina Safamanesh [Iran] ; Ali Mousavimaleki [Iran] ; Mohammad Taghi Rezaei [Iran] ; Maziar Faridi [Iran] ; Somayeh Mokhber [Iran] ; Abdolreza Pazouki [Iran] ; Saeed Safari [Iran]	Bariatric Surgical Practice During the Initial Phase of COVID-19 Outbreak
000948 (2019)	Fatemeh Sanie-Jahromi [Iran] ; Masoomeh Eghtedari [Iran] ; Esmaeil Mirzaei [Iran] ; Mohammad Hassan Jalalpour [Iran] ; Zahra Asvar [Iran] ; Mahmood Nejabat [Iran] ; Fahimeh Javidi-Azad [Iran]	Propagation of limbal stem cells on polycaprolactone and polycaprolactone/gelatin fibrous scaffolds and transplantation in animal model
000C05 (2019)	Xiaoying Sun [République populaire de Chine] ; Raheleh Roudi [Iran] ; Ting Dai [République populaire de Chine] ; Shangya Chen ; Bin Fan [République populaire de Chine] ; Hongjin Li [République populaire de Chine] ; Yaqiong Zhou [République populaire de Chine] ; Min Zhou [République populaire de Chine] ; Bo Zhu [États-Unis] ; Chengqian Yin [États-Unis] ; Bin Li [République populaire de Chine] ; Xin Li [République populaire de Chine]	Immune-related adverse events associated with programmed cell death protein-1 and programmed cell death ligand 1 inhibitors for non-small cell lung cancer: a PRISMA systematic review and meta-analysis
000C21 (2019)	Hassan Yousefi [Iran] ; Majid Momeny [Iran] ; Seyed H. Ghaffari [Iran] ; Nazanin Parsanejad [Iran] ; Arash Poursheikhani [Iran] ; Sepehr Javadikooshesh [Iran] ; Ghazaleh Zarrinrad [Iran] ; Fatemeh Esmaeili [Iran] ; Zivar Alishahi [Iran] ; Zahra Sabourinejad [Iran] ; Ghazaleh Sankanian [Iran] ; Sahar Shamsaiegahkani [Iran] ; Davood Bashash [Iran] ; Narjes Shahsavani [Canada] ; Javad Tavakkoly-Bazzaz [Iran] ; Kamran Alimoghaddam [Iran] ; Ardeshir Ghavamzadeh [Iran]	IL-6/IL-6R pathway is a therapeutic target in chemoresistant ovarian cancer.
001774 (2017)	Forouhe Zahir-Jouzdani [Iran] ; Fatemeh Atyabi [Iran] ; Nazanin Mojtabavi	Interleukin-6 participation in pathology of ocular diseases.
001816 (2017)	Arman Ahmadzadeh [Iran] ; Alireza N. Farahmand [Iran] ; Latif Gachkar [Iran]	Evaluation of safety, efficacy and post-cessation efficacy durability of tocilizumab in patients with active rheumatoid arthritis.
001C14 (2016)	Amir Hashemi-Meshkini [Iran] ; Shekoufeh Nikfar [Iran] ; Elizabeth Glaser [États-Unis] ; Ahmadreza Jamshidi [Iran] ; Seyed Alireza Hosseini [Iran]	Cost-Effectiveness Analysis of Tocilizumab in Comparison with Infliximab in Iranian Rheumatoid Arthritis Patients with Inadequate Response to tDMARDs: A Multistage Markov Model.
001F10 (2015)	Mohammed Hammoudeh [Qatar] ; Adel Al Awadhi [Koweït] ; Eman Haji Hasan [Koweït] ; Maassoumeh Akhlaghi [Iran] ; Arman Ahmadzadeh [Iran] ; Bahar Sadeghi Abdollahi [Iran]	Safety, Tolerability, and Efficacy of Tocilizumab in Rheumatoid Arthritis: An Open-Label Phase 4 Study in Patients from the Middle East.
002125 (2015)	Haydarali Esmaili [Iran] ; Elmira Mostafidi [Iran] ; Bahareh Mehramuz [Iran] ; Mohammadreza Ardalan [Iran] ; Mohammadali Mohajel-Shoja [États-Unis]	An update on renal involvement in hemophagocytic syndrome (macrophage activation syndrome)
002168 (2015)	Rosanna Abbate [Italie] ; Nasser M. Al-Daghri [Arabie saoudite] ; Paolo Andreozzi [Italie] ; Niels Borregaard [Danemark] ; Günay Can [Turquie] ; Gianluca Caridi [Italie] ; Maren Carstensen-Kirberg [Allemagne] ; Gabriele Cioni [Italie] ; Enrico Conte [Italie] ; Rosario Cuomo [Italie] ; Marie A. Denis [Belgique] ; Gohar Fakhfouri [Canada] ; G. Fakhfouri [Canada] ; Renné Fiasse [Belgique] ; Andreas Glenth J [Danemark] ; Georg Goliasch [Autriche] ; Thomas Gremmel [Autriche, États-Unis] ; Christian Herder [Allemagne] ; Maria Iemmolo [Italie] ; Zhi-Cheng Jing [République populaire de Chine] ; Robert Krause [Autriche] ; Oreste Marrone [Italie] ; Bartosz Miazgowski [Pologne] ; Tomasz Miazgowski [Pologne] ; Lorenzo Minchiotti [Italie] ; Kazem Mousavizadeh [Iran] ; Gjin Ndrepepa [Allemagne] ; Alexander Niessner [Autriche] ; Cristina Ogayar Luque [Espagne] ; Altan Onat [Turquie] ; Ioannis Papassotiriou [Grèce] ; Martín Ruiz Ortiz [Espagne] ; Shaun Sabico [Arabie saoudite] ; C. Mary Schooling [États-Unis] ; Sophia D. Sakka [Royaume-Uni] ; P. Sołtysiak [Pologne] ; Frank L. J. Visseren [Pays-Bas] ; Jasmin Wagner [Autriche] ; Xiao-Jian Wang [République populaire de Chine] ; Jan Westerink [Pays-Bas]	Research update for articles published in EJCI in 2013
002551 (2014)	Gholamreza Azizi [Iran] ; Roobina Boghozian [Iran] ; Abbas Mirshafiey [Iran]	The potential role of angiogenic factors in rheumatoid arthritis
002800 (2013)	Seema Kalra [Royaume-Uni] ; Alan Silman [Royaume-Uni] ; Gulsen Akman-Demir [Turquie] ; Saeed Bohlega [Arabie saoudite] ; Afshin Borhani-Haghighi [Iran] ; Cris S. Constantinescu [Royaume-Uni] ; Habib Houman [Tunisie] ; Alfred Mahr [France] ; Carlos Salvarani [Italie] ; Petros P. Sfikakis [Grèce] ; Aksel Siva [Turquie] ; Adnan Al-Araji [Royaume-Uni]	Diagnosis and management of Neuro-Behçet’s disease: international consensus recommendations
003A92 (2011)	Kamal Esalatmanesh [Iran] ; Raika Jamali [Iran] ; Arsia Jamali [Iran] ; Bardia Jamali [Iran] ; Mohammadreza Nikbakht [Iran]	Serum anti-cyclic citrullinated peptide antibodies may predict disease activity in rheumatoid arthritis

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Merge

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Merge/AffPays.i -k "Iran" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Merge/AffPays.i  \
                -Sk "Iran" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Merge/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Merge
   |type=    indexItem
   |index=    AffPays.i
   |clé=    Iran
}}

---

This area was generated with Dilib version V0.6.34. Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021